This month, Australia announced its 2015 budget, the first budget presented by the new conservative prime minister. Funding for several research agencies will decline, including an AUD 111.4 million ($103.0 million) cut for the Commonwealth Scientific and Industrial Research Organization, and AUD 120 million less for the Defense Science and Technology Organization. Funding for the […]
The annual R&D survey conducted in March and April by Food Processing found that among 215 respondents, half engaged in open innovation. New product development will be the top priority this year for 39% of companies. R&D budgets remained about the same compared to last year for 47% of respondents, while 23% reported increases and […]
In late 2013, the Tufts Center for the Study of Drug Development studied personalized medicines in the stages beyond Phase II trials. The information used was compiled from commercial databases, public sources and the Center’s own database. Out of 580 identified products, 66 were likely to be marketed as personalized medicines on approval, although a […]
The EPA proposed this month more stringent restrictions on emissions from the 149 petroleum refineries in the US. The new rule would require monitoring of air at refinery fencelines to ensure compliance with standards. Coking units, tanks and flares would be subject to increased emission-control requirements, and the operational requirements of flares would be adjusted […]
Washington, DC 5/22/14—Roka Biosciences has filed to raise $75.0 million through a US IPO. Roka plans to list its shares on the NASDAQ stock exchange. Pricing details were not announced. Roka offers the Atlas instrument and Atlas Detection Assays for molecular-based automated foodborne-pathogen testing. Roka supplies tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin–producing […]
San Diego, CA 5/30/14; San Diego, CA 5/30/14—Sequenom has sold its Bioscience unit to Agena Bioscience, a Telegraph Hill Partners company, for $31.8 million and contingent consideration of up to $4 million. The Bioscience business manufactures and sells the MALDI-TOF MS–based MassARRAY platform for genetic analysis in research and clinical labs. Agena will retain all […]
Hilden, Germany and Germantown, MD 5/20/14—QIAGEN has acquired BIOBASE, a provider of expertly curated biological databases, for an undisclosed amount. BIOBASE products include the HGMD Human Gene Mutation Database on human inherited-disease mutations and the PGMD PharmacoGenomic Mutation Database, which identifies all published gene variants that affect patient drug response. “With HGMD and other content […]
New York, NY 5/22/14—The Wall Street Journal reported that VWR is in talks about a possible IPO or sale, according to sources. VWR and owner Madison Dearborn Partners have talked with banks in recent weeks about an IPO to raise $750 million. Such an offering would value the equity in VWR at $4 billion. As […]
New York, NY 5/29/14—Citing anonymous sources, Bloomberg has reported that Thermo Fisher Scientific intends to sell its Cole-Parmer Instrument business, which supplies lab equipment. Cole-Parmer has annual EBITDA of $50 million. The sources stated the sale price could range from $500 million to $700 million. Thermo acquired Cole-Parmer as part of its 2006 purchase of […]
The calendar year first quarter provided few clear trends as large publicly held US analytical and life science instrument firms experienced mixed results, with strengths and weaknesses in market and geographic segments varying by company. The six laboratory instrument and product businesses whose quarterly revenues are detailed on pages 9–11 reported positive sales results for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
